A multicenter, double-blind, randomized, parallel group, 6-week study to evaluate the efficacy and safety of ezetimibe/simvastatin combination tablet versus atorvastatin in patients with hypercholesterolemia.

Trial Profile

A multicenter, double-blind, randomized, parallel group, 6-week study to evaluate the efficacy and safety of ezetimibe/simvastatin combination tablet versus atorvastatin in patients with hypercholesterolemia.

Completed
Phase of Trial: Phase III

Latest Information Update: 15 Mar 2017

At a glance

  • Drugs Atorvastatin; Ezetimibe/simvastatin
  • Indications Hypercholesterolaemia
  • Focus Registrational; Therapeutic Use
  • Acronyms VYVA
  • Most Recent Events

    • 30 Aug 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top